Improved formula. Fos-A-Dophilus now utilises GUARD technology; a patented, innovative and natural technology proven to protect the bacterial strains from stomach acid and enable the timed release of the live bacteria within the intestines.
Bifidobacterium longum (RO175), Lactobacillus rhamnosus GG, Lactobacillus animalis ssp lactis (lafti® B94), Bifidobacterium breve (HA-129), Bifidobacterium infantis (ROO33), Lactobacillus acidophilus (RO418), potato starch, NutraJIT® (GUARD technology), hydroxypropyl methylcellulose (capsule shell).
Potato starch, NutraJIT®
Total Live cultures: 4 billion CFU
| Name | Amount | % NRV* |
|---|---|---|
| Bifidobacterium Longum | 52 % | ✝ |
| Lactobacillus rhamnosus | 30 % | ✝ |
| Lactobacillus animalis ssp lactis | 5 % | ✝ |
| Bifidobacterium breve | 5 % | ✝ |
| Bifidobacterium infantis | 5 % | ✝ |
| Lactobacillus Acidophilus | 3 % | ✝ |
|
* NRV is the Nutrient Reference Value
✝ NRV not yet established |
||
This product is hypoallergenic / does not contain any of the 14 major allergens listed in Annex II (1169/2011) of the EU Food Information for Consumers Regulation.
1-2 capsules daily, or as directed by a practitioner. For travel: Start taking Fos-A-Dophilus for at least 7 days prior to the start of your journey. During travel take the recommended daily dose, and continue to do so for at least 7 days following th
Store in a cool, dry place away from direct sunlight and heat
This product is suitable for the following requirements:
